GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

Europe: Groundbreaking embryonic stem cell study gets green light

27/9/2011

U.K. regulators have given the green light to a small but groundbreaking embryonic stem cell treatment advanced by the Marlborough, MA-based biotech Advanced Cell Technology for Stargardt's macular dystrophy, an incurable disease. This is the first such ESC trial in Europe.  More...

 

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Stem Cells and Autism
18 September 2011